Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) Stock Plummets After Angelman Syndrome Drug Trial Failure and Analyst Downgrade
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameTactical Resources Corp
-
Registration countryCanada
-
IndustryMining: Other
-
М/S&P/F
*** /*** /***









